Literature DB >> 8806091

Cell culture methods for the establishment of the NCI series of lung cancer cell lines.

H K Oie1, E K Russell, D N Carney, A F Gazdar.   

Abstract

More than 200 human small cell lung cancer and non-small cell lung cancer cell lines were established over 15 years mainly by utilizing the serum-free, hormone and growth factor supplemented, defined media HITES and ACL4. Use of modified, established cell culture techniques such as the mechanical spillout method for the releasing of cell aggregates from tumor tissue, ficoll gradient centrifugation for the separation of tumor cells from erythrocytes and tissue debris, and an apparatue consisting of a platinum tubing attached to a suction flask for removal of spent medium have greatly contributed to the success in culturing tumor cells. Characterization of these lung cancer cell lines have extended our knowledge of lung cell biology. Studies elucidating the nutritional requirements of lung cancer cell growth may be helpful for the manipulation of these tumors in patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806091     DOI: 10.1002/jcb.240630504

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  23 in total

Review 1.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Authors:  Adi F Gazdar; Boning Gao; John D Minna
Journal:  Lung Cancer       Date:  2010-01-15       Impact factor: 5.705

2.  Establishment and characterization of a lung cancer cell line, SMC-L001, from a lung adenocarcinoma.

Authors:  So-Jung Choi; Hyeseon Lee; Chungyoul Choe; Yong-Sung Shin; Jinseon Lee; Sung-Hwan Moon; Jhingook Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-02-26       Impact factor: 2.416

Review 3.  Lung cancer cell lines as tools for biomedical discovery and research.

Authors:  Adi F Gazdar; Luc Girard; William W Lockwood; Wan L Lam; John D Minna
Journal:  J Natl Cancer Inst       Date:  2010-08-02       Impact factor: 13.506

4.  Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene.

Authors:  J Xian; K J Clark; R Fordham; R Pannell; T H Rabbitts; P H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

5.  Establishment and characterization of primary lung cancer cell lines from Chinese population.

Authors:  Chao Zheng; Yi-hua Sun; Xiao-lei Ye; Hai-quan Chen; Hong-bin Ji
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

6.  Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines.

Authors:  Nadiya Sosonkina; Seung-Keun Hong; Dmytro Starenki; Jong-In Park
Journal:  Genes Genomics       Date:  2014-12       Impact factor: 1.839

Review 7.  Emerging Opportunities for Target Discovery in Rare Cancers.

Authors:  Tanaz Sharifnia; Andrew L Hong; Corrie A Painter; Jesse S Boehm
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

8.  Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.

Authors:  M Wislez; J Fleury-Feith; N Rabbe; J Moreau; D Cesari; B Milleron; C Mayaud; M Antoine; P Soler; J Cadranel
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

9.  Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report.

Authors:  Xavier Tekpli; Vidar Skaug; Rita Bæra; David H Phillips; Aage Haugen; Steen Mollerup
Journal:  Cell Oncol (Dordr)       Date:  2016-08-29       Impact factor: 6.730

10.  WNT7a induces E-cadherin in lung cancer cells.

Authors:  Tatsuo Ohira; Robert M Gemmill; Kevin Ferguson; Sophie Kusy; Joëlle Roche; Elisabeth Brambilla; Chan Zeng; Anna Baron; Lynne Bemis; Paul Erickson; Elizabeth Wilder; Anil Rustgi; Jan Kitajewski; Edward Gabrielson; Roy Bremnes; Wilbur Franklin; Harry A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.